Collaborating for What’s Now & What’s Next: 1859 Devon Cayer, CEO & Co-Founder of 1859, shares how 1859 has teamed up with JLABS @ San Diego to miniaturize the medicine delivery process. Related content Related video Related videos Collaborating for What’s Now & What’s Next: 1859 Related article Related articles 16 February 2021 Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders Full article 10 February 2021 Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement Full article